Cargando…
Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways
Autores principales: | Refaie, Marwa M. M., Rifaai, Rehab Ahmed, Fawzy, Michael Atef, Shehata, Sayed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066064/ https://www.ncbi.nlm.nih.gov/pubmed/36857015 http://dx.doi.org/10.1007/s12012-023-09787-5 |
Ejemplares similares
-
RETRACTED ARTICLE: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways
por: Refaie, Marwa M. M., et al.
Publicado: (2022) -
Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway
por: International, BioMed Research
Publicado: (2023) -
Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Publicado: (2019) -
Retracted: Efficacy of Dapagliflozin in Patients with Diabetes Mellitus Complicated with Coronary Artery Disease and Its Impact on the Vascular Endothelial Function
por: Markers, Disease
Publicado: (2023) -
Retracted: The Value of Left Atrial Volume Changes in Predicting Cardiotoxicity in Patients Undergoing Anthracycline Chemotherapy
por: Healthcare Engineering, Journal of
Publicado: (2023)